CytomX Therapeutics Inc.

CTMX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.79

+$0.03 (+1.09%)

Sep 22, 2026, 12:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-17.37M	31.87M	-569K	-99.32M	-83.61M	-32.89M
Depreciation & Amortization	1.38M	1.77M	2.18M	5.86M	2.71M	2.57M
Stock-Based Compensation	6.3M	7.67M	8.56M	13.13M	13.17M	14.79M
Other Working Capital	-69.89M	-126.45M	-93.64M	4.47M	-66.21M	30.89M
Other Non-Cash Items	2.68M	-1.12M	-3.69M	13.33M	3.13M	2.89M
Deferred Income Tax	n/a	n/a	n/a	n/a	272K	-236K
Change in Working Capital	-68.58M	-126.42M	-62.51M	-30.65M	-54.7M	18.13M
Operating Cash Flow	-75.59M	-86.23M	-56.04M	-110.79M	-119.03M	5.26M
Capital Expenditures	-220K	-310K	-840K	-1.74M	-1.61M	-2.31M
Cash Acquisitions	n/a	n/a	n/a	n/a	-24.1M	16.41M
Purchase of Investments	-192.52M	-155.49M	-424.83M	n/a	-99.9M	-199.11M
Sales Maturities Of Investments	133M	255.5M	275M	100M	124M	182.7M
Other Investing Acitivies	n/a	n/a	n/a	n/a	24.1M	-16.41M
Investing Cash Flow	-59.74M	99.7M	-150.67M	98.26M	22.49M	-18.72M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	613K	n/a	n/a	2.5M	5.61M
Financial Cash Flow	110.45M	7.52M	30.23M	648K	110.21M	16.89M
Net Cash Flow	-24.89M	20.99M	-176.48M	-11.88M	13.67M	3.43M
Free Cash Flow	-75.81M	-86.54M	-56.88M	-112.53M	-120.64M	2.95M
Adj. Free Cash Flow	-82.11M	-94.21M	-65.43M	-125.65M	-133.81M	-11.84M
Maintenance CapEx	-220K	n/a	n/a	n/a	-1.61M	n/a
Growth CapEx	n/a	-310K	-840K	-1.74M	n/a	-2.31M
Owner Earnings	-75.81M	-86.23M	-56.04M	-110.79M	-120.64M	5.26M